The Massachusetts sequencing firm has been selling technology originally developed by Helicos BioSciences and planned to increase marketing with the IPO proceeds.
The company plans to raise $25 million in a Series B financing round. It is also working on a two-color chemistry and aims to develop an instrument for clinical applications.
NEW YORK (GenomeWeb) – Startup SeqLL has closed a $1 million Series A financing round, which it said it will use to enhance Helicos BioSciences' single-molecule sequencing technology for scientific and diagnostic applications. Genomic Diagnostic Technologies led the investment.
Authors of a recent study in BMC Research Notes have concluded that archeological control testing and targeted verification testing are key to avoiding false-positive pathogen identification when
NEW YORK (GenomeWeb News) – Researchers at Brown University and the St. Laurent Institute have found ties between RNA editing and transposon-related gene silencing in fruit flies — findings that they suspect may extend to other organisms.
NEW YORK (GenomeWeb News) – The US bankruptcy court in charge of Helicos BioSciences' Chapter 11 bankruptcy reorganization has approved deals for the company to license its intellectual pr
NEW YORK (GenomeWeb News) – Defunct next-generation sequencing technology firm Helicos BioSciences has asked a bankruptcy court to approve the licensing of intellectual property to Illumina, Life Technologies, and Fluidigm.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
